The Net Margin of Calliditas Therapeutics AB (CALTX.ST) is -38.63%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2023-12-31 | -38.63% |
2022-12-31 | -51.35% |
2021-12-31 | -218.14% |
2020-12-31 | -49598.86% |
2019-12-31 | -17.63% |